MedPath

The dopaminergic system in pornography addiction.

Conditions
pornographic addiction
Therapeutic area: Body processes [G] - Physiological processes [G07]
Registration Number
EUCTR2014-001284-12-NL
Lead Sponsor
niversity Medical Center Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

- male sex
- age between 18 and 45
- a modified CIUS score>3
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 28
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- lifetime DSM-IV axis I disorder,
- drug dependence or abuse; including alcohol (i.e. drinking more than 30 drinks per month or any illicit drug use during the past 30 days);
- active medical condition;
- treatment in the last 6 months with antidepressants, neuroleptics, sedative hypnotics, glucocorticoids, appetite suppressants, sex hormone, opiate or dopamine medications
- use of psychoactive medications within the past 30 days;
- lifetime history of seizure disorder or closed head trauma;
- participation in a scientific research study (<1 year) involving radiation
- Contra-indications for MRI-scanning

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: The primary objective is to determine the dopamine D2 receptor availability and dopaminergic function in subjects with pornographic addiction and to compare the availability with control subjects.;Secondary Objective: The secondary objectives are to correlate the dopamine D2 receptor availability to prefrontal cerebral blood flow, the severity of addiction as measured by the Compulsive Internet Use Scale (CIUS), and personality traits of impulsivity and sensation seeking.;Primary end point(s): n/a;Timepoint(s) of evaluation of this end point: n/a
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): n/a;Timepoint(s) of evaluation of this end point: n/a
© Copyright 2025. All Rights Reserved by MedPath